Pancreatic cancer patients in Ukraine treated with TSE continues to have a good quality of life
Scandinavian ChemoTech has received encouraging updated information from Ulis Hospital Ukraine, which states that the performance status of the treated pancreatic cancer patients continues to be good close to six months after treatment.The two unresectable pancreatic cancer patients at Ulis Hospital in Ukraine who received TSE treatments in combination with a low dose of chemotherapy, using ChemoTech’s IQwave™ device six months back, continue to have a good quality of life with an ECOG score of 1, and are not on any pain relief medication. Both patients are restricted from physically